Our Guest Speakers
Why Attend Clinical Research Alliance Inaugural Conference on Diversity: Inclusion & Inclusion In Clinical Trials?
Accessibility and availability of state-of-the-art clinical trials has been consistently recognized as a glaring unmet need in diverse and underserved communities in the United States. Indeed, the National Institutes of Health Minority Health and Health Disparities Strategic Plan 2021-2025 was developed by NIMHD, in collaboration with all the NIH Institutes, to outline NIH’s commitment to improving minority health and reducing health disparities. Two of the Strategic Plan’s major goals focus on issues of diversity and inclusion in NIH-funded research and in clinical trials as follows:
This mandate has led the Clinical Research Alliance to develop a model of offering the options of modern cancer clinical trials to diverse and underserved communities at risk that previously had not had the opportunity to participate unless they out migrated to referral centers, many of which were not practically available to them. In addition, cultural, language and medical literacy issues were not reconciled in most areas, and funding to supplement deficiencies have been lacking. The purpose of this conference therefore, is to raise awareness among the communities at large, as well as provide practical and actionable information to interested and committed stakeholders, from industry to health care providers across the spectrum of involvement.
Senior Executive Advisor
Blair Childs is Senior Vice President of Public Affairs for Premier, leading the Advocacy, Communications, Safety and thought leadership units and serving on the company’s executive team. He works with the Congress, White House, and other policymakers involved in health policy
Senior Vice President, Clinical Research Alliance
Cynthia has 30 years in specialty distribution, pharmaceutical industry, and Oncology. In her current role, Cynthia is Senior Vice President of Clinical Research Alliance. Cynthia worked 17 years at Innovatix/Premier as managing all specialty pharmacy and Oncology focus initiatives...Read More
James D’Olimpio, M.D., FACP, FAAHPM
Clinical Research Alliance
James T. D’Olimpio, M.D., FACP, FAAHPM is the Principal Investigator and Consultant for the Clinical Research Alliance and was the former Director of Supportive/Palliative Oncology at North Shore University Hospital /Monter Cancer Center at the Northwell Cancer Institute from 1997-2020....Read More
President & CEO, Clinical Research Alliance
John Sganga is currently President and Chief Executive Officer of Clinical Research Alliance, Inc. (CRA). In this role he is bringing much needed clinical trial opportunities to diverse communities. A key objective is to extend life and treat patients within their local setting. On August 25, 2022, Mr. Sganga was appointed Chairman and Chief Executive Officer of CRA’s parent company, Optimus Healthcare Services, Inc...Read More
Muhammad Kafeel, MD, Vantage Health
Board-Certified Hematologist and Medical Oncologist, Muhammad Imran Kafeel, has two decades of experience in providing individualized, compassionate cancer care to patients in the New York area. Dr. Kafeel has been distinguished as a Castle Connolly Top Doctor and recognized in the Guide to American’s top Physicians. He is a renowned linguist and has volunteered his multilingual medical expertise to humanitarian missions such as the Disaster Relief fund...